| EMA number | EMEA/H/C/000679 |
| ATC code | C02KX03 |
| Authorisation | 10 August 2006 |
| Withdrawn | 6 January 2011 |
| Revision | 13 |
Treatment of patients with pulmonary arterial hypertension (PAH) classified as WHO functional class III, to improve exercise capacity. Efficacy has been shown in primary pulmonary hypertension and in pulmonary hypertension associated with connective tissue disease.